Skip to content

PR-Web

Press releases worldwide

  • Home
  • Contact
  • Datenschutzerklärung
  • Legal notice

Author: Firma EMBL Heidelberg

Using artificial intelligence to discover therapeutic antibodies

Posted on 14. December 202315. December 2023 by Firma EMBL Heidelberg Posted in Research / Development Tagged aion, biomed, cancer, discovery, drugs, embl, financial, heidelberg, marking, merck, new, research, strong, therapy, with

Former EMBL staff scientist founds a start-up – DenovAI – for broader, faster and cheaper antibody discovery using advanced machine learning and computational biophysics Antibodies are an important tool in the human immune system’s arsenal against disease. They attach to […]

Read More

EMBL Research News: International study proposes stool analysis for early detection of pancreatic cancer

Posted on 8. March 20229. March 2022 by Firma EMBL Heidelberg Posted in Research / Development Tagged cancer, cells, disease, embl, heidelberg, kit, lethal, metastatic, microbiome, pancreatic, research, samples, signature, stool, study

Pancreatic cancer is one of the most lethal cancers due to its early local extension and metastatic behaviour. Some of the reasons for this high fatality rate are late diagnosis of the disease, especially since symptoms are unspecific and appear […]

Read More

EMBL-Research: The impact of drugs on gut microbes is greater than we thought

Posted on 9. December 20219. December 2021 by Firma EMBL Heidelberg Posted in Research / Development Tagged coronary, diabetes, disease, drugs, embl, heidelberg, leipzig, mask, mdc, medical, microbiome, patients, study, treatment, with

We are one of the most medicated generations of humans to live on our planet. Cardiometabolic diseases like type 2 diabetes, obesity, and coronary artery disease continue to increase in prevalence and together constitute the highest cause of mortality worldwide. […]

Read More

Structural biology reveals new opportunities to combat tuberculosis

Posted on 28. June 2021 by Firma EMBL Heidelberg Posted in Research / Development Tagged bcg, beckham, cell, cells, drugs, embl, heidelberg, new, research, security, treatment, vaccine, vaccines, weapons, with

Tuberculosis is one of the top ten causes of death worldwide, infecting about one-quarter of the world’s population. Although it is treatable, the rise of multidrug-resistant tuberculosis poses a major threat to global health security, and has been declared by […]

Read More

Scientists identify synthetic mini-antibody to combat COVID-19

Posted on 4. November 20204. November 2020 by Firma EMBL Heidelberg Posted in Research / Development Tagged cell, cells, cov, covid, cssb, domains, embl, lab, mini, rbds, research, sars, switch, treatment, with

Llama mini-antibodies and their synthetic imitations The ability of SARS-CoV-2 to infect cells depends on interactions between the viral spike protein and the human cell surface protein ACE2. To enable the virus to hook onto the cell surface, the spike […]

Read More

Fighting cardiovascular disease with acne drug

Posted on 8. September 2020 by Firma EMBL Heidelberg Posted in Research / Development Tagged cardiomyocytes, cell, cells, cms, dcm, embls, genome, heidelberg, new, patients, rbm20, trans, transplant, valve, with

Researchers from the European Molecular Biology Laboratory in Heidelberg and Stanford University have found the cause of dilated cardiomyopathy – a leading cause of heart failure – and identified a potential treatment for it: a drug already used to treat […]

Read More

How to remove unwanted components from the cell nucleus

Posted on 2. September 2020 by Firma EMBL Heidelberg Posted in Research / Development Tagged biotech, cell, cells, embl, genomics, heidelberg, hring, imba, lab, mina, mitosis, research, rna, stem, with

An international team of scientists has uncovered how cells remove unwanted components from the nucleus following mitosis. The results, published in the journal Nature, stem from a fruitful collaboration between the European Molecular Biology Laboratory in Heidelberg and the Institute […]

Read More

Bridging artificial intelligence and the life sciences – launch of ELLIS Heidelberg

Posted on 6. August 2020 by Firma EMBL Heidelberg Posted in Research / Development Tagged cancer, dkfz, embedded, embl, genomics, heidelberg, imaging, kreshuk, learning, machine, medical, new, research, stegle, with

A newly established research unit will support artificial intelligence and machine learning in the life sciences, and will link its activities in Heidelberg with other research institutes internationally. The unit is part of ELLIS – the European Laboratory for Learning and […]

Read More

Life sciences open their doors for engineers

Posted on 15. June 2020 by Firma EMBL Heidelberg Posted in Research / Development Tagged accelerator, embl, genomics, heidelberg, horizon, imaging, new, platform, project, research, services, stamp, stem, technology, with

The European Molecular Biology Laboratory has secured 6.8 million Euros funding from the European Commission to launch a unique training programme. The ARISE Programme will train and develop Europe’s next generation leadership for research infrastructures in the life sciences. Research […]

Read More

New insights into epigenetic modifications

Posted on 11. June 2020 by Firma EMBL Heidelberg Posted in Research / Development Tagged cells, edwards, embl, epigenetic, fruit, genome, lab, methylation, new, origin, research, rna, sugar, transposons, with

Scientists at EMBL Rome unveil the mechanism behind the most studied epigenetic modification. The press release including visuals can be found here: https://www.embl.org/news/science/new-insights-into-epigenetic-modifications/  ‘DNA makes RNA makes protein’ is a fundamental principle in molecular biology. The process of gene expression, namely […]

Read More

Copyright 2016. All rights reserved.


Back To Top
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkRead more